Regulatory, Equity, Diversity & Inclusion Leaders

Dr. Isaac R. Rodriguez-Chavez is a biomedical and regulatory leader with expertise in Infectious Diseases, Viral Immunology, Viral Oncology (Infectious Diseases), and Vaccinology. Currently, he is an independent consultant for Scientific, Clinical and Regulatory affairs. Past positions in the last 30+ years include: Senior Vice President for Scientific, Clinical Affairs, leading the Strategy of the Global Center of Excellence for Decentralized Clinical Trials at PRA Health Sciences and ICON plc; FDA, CDER Senior Officer for Clinical Research Methodology, Regulatory Compliance and Policy Development modernizing clinical research through Real World Evidence and Decentralized Clinical Trials enabled by Digital Health Technologies and electronic Clinical Outcome Assessments (eCOAs); CEO and Founder, 4Biosolutions Biomedical Consulting Firm; Vice President, Research, Texas Biomedical Research Institute; Director of HIV Clinical Research Programs at National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH); Senior Clinical Scientist, Schering Plough Corp. – Merck & Corp.; Scientist, Columbia University; Scientist, Polar Biotechnology Company and Venezuelan Institute for Scientific Research (IVIC). He has a PhD in Virology and Immunology; a MS in Microbiology; a MHS in Clinical Research and Health Sciences; and a B.S. in Biology. He also has 5 years of postdoctoral specialty experience in Clinical Research (phases 1 & 2 trials) linked to in AIDS Malignancies, Immuno-Oncology and Viral Immunology (Infectious Diseases) done at the U.S. NIA and NCI, NIH.

Dr. Rodriguez-Chavez is a Founding Board Member of the Digital Medical Society (DiME). He is also a co-chair of the DiME’s Research Committee, driving digital medicine globally. He is a regulatory Advisor and Vice-Chair of the Institute of Electrical and Electronics Engineers (IEEE) fostering industry standards on DCTs and DHTs. He is a former Leadership Council Board Member of the Decentralized Trials & Research Alliance (DTRA). He is a Board Member of the Hypertrophic Cardiomyopathy Association (HCMA) and a Health Equity Board Council Member for equity, diversity and inclusion in rare diseases at the Global Genes. He is a global content editor for regulatory science and an Editorial Board Member of the DIA Global Forum Magazine. He is also an active member of sixteen professional associations, including the Infectious Disease Society of America, American Federation for Medical Research, American Association of Immunologists, American Society for Virology, American Society of Microbiology, Society of Quality Assurance, Association of Clinical Research Professionals, New York Academy of Sciences, International AIDS Society, International Association for Dental Research, American Association for Dental Research, and Regulatory Affairs Professional Society.

LinkedIn: https://www.linkedin.com/in/isaacrc/

Dr. Adams serves as the Chairman of the Board for The Association of Diversity in Clinical Trials. Adams also currently serves as Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th United States Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic, including working with companies to increase diversity in vaccine trials. As the Chairman of the Board, Adams provides his in-depth knowledge of patient perspectives and industry views on diversity to create sustainable solutions and best practices to establish more diverse representation in clinical trials.

Expertise in the following areas:

A. Provide General Counsel/ Chief Compliance Officer services to life sciences companies, CROs, SMOs, and advertising companies with risk oversight by complying with a variety of legal, regulatory, and compliance issues including the Code of Federal Regulations, the False Claims Act, Anti-Kickback Law, HIPAA, Stark Laws, Foreign Corrupt Practices Act, etc. by adhering to the requirements suggested by the OIG, DOJ, US Attorney’s Offices, the FDA, and other governmental and non-governmental organizations.

B. Clinical trial negotiation services for, and against, investigators, CROs, and sponsors.
a. Formulation of letters of indemnification,
b. Negotiation of payment schedules,
c. Budget determination,
d. formulation and negotiation of master services agreements.

C. Assuring Quality, Regulatory and Legal Services
a. Review, presentation, and response to 483s, Warning Letters, and other titled and untitled FDA letters,
b. Systematic implementation and training of a comprehensive SOP program,
c. Review of promotional materials and actions of sales and scientific staff to ensure legal, regulatory, and medical compliance,
d. Conducting product recalls.

D. Apply for state and federal licensure with boards of pharmacy, attorney general’s offices, etc. for manufacturing and distribution facilities.

E. Building compliance systems within companies.

LinkedIn: https://www.linkedin.com/in/darshankulkarni/

Dr. Foster is the President and Chief Diversity Officer for the Association of Diversity in Clinical Trials and the Founder and CEO of TOTAL Diversity Clinical Trial Management, a full-service integrated diversity organization. From 2016 through 2022, Dr. Foster served as Vice President of Diversity, Equity, and Inclusion for the Society of Clinical Research Sites (SCRS), where she authored the Diversity Site Assessment Tool (DSAT). Dr. Foster has written six industry books and several current research studies focused on site perspectives in diversity. Dr. Foster is a recognized thought leader and sought after expert in diversity and clinical site best practices.

Known as “Doc” Griggs, he is responsible for developing, implementing, and monitoring programs and initiatives that improve the overall health and well-being of the communities we serve. With over 13 years of experience in health education, promotion, and equity – nationally and internationally, he is passionate about creating and executing strategies that address the social determinants of health, increase access to care, and promote health equity for underserved populations.

He also serves as an Adjunct Assistant Professor, a National Advisory Board Member, a Medical Contributor, and a Health Equity Ambassador, among other positions, that allow him to share his knowledge, skills, and expertise in various domains of public health, wellness, and medicine.  He is a certified trainer, facilitator, and instructor in several areas, such as workplace wellness, nature prescription, cycling, and life reimagining. The founder and executive director of Doc Griggs Foundation, a non-profit organization that aims to empower communities to “Get Checked, Get Fit, Get Moving!” through education, advocacy, and outreach.

LinkedIn:  https://www.linkedin.com/in/eric-griggs-md-147a7557/

A registered pharmacist with a doctorate in pharmacy, Ryan is always searching for better ways to improve healthcare. He has experience in both clinical research and clinical trial review and is responsible for scientific review and counsel on BlueCloud initiatives. He currently works as a pharmacist in a large national pharmacy chain and is always looking to bring new and innovative processes to standardize and streamline the healthcare process.  Ryan lost family to stroke and cancer.

Mr. Toro is an accomplished consultant and entrepreneur with 28 years of experience. As president and CEO of his own Software Engineering firm, Toro Technologies, Inc., he developed a successful business which delivered critical path systems for MasterCard, AT&T Universal Card, Global Payment Systems and others in the payment industry. Mr. Toro successfully sold his company to PaylinX Corporation (later acquired by publicly traded Cybersource). After his exit, Mr. Toro has worked for over 10 years in structuring capital for growth for his own ventures and others across the Americas. Mr. Toro has an extensive background in Information Technology with emphasis in electronic transaction processing and healthcare information systems.

LinkedIn: https://www.linkedin.com/in/jorgetoroayala/

Mr. Pacino is a well known industry KOL. A 16 year head and neck cancer survivor, a US Army veteran and a senior executive with over 35 years experience in healthcare and clinical research. Inventor GDPRWallet®, Trust&Verify on BlueCloud. Patient Diversity Advocate and Co-Founder and current President of BlueCloud by HealthCarePoint, a leading global PRIVACY / GDPR Based Network of over 2,100,000+ healthcare and clinical research professionals in the neurosciences, Cardiovascular, CNS and other therapeutic verticals, from more than 500,000+ organizations, focused on providing globally standardized training, education and certifications (NIH Stroke Scale, mRS Rankin, Suicidality (C-SSRS), Barthel Index (BI), + dozens more patient focused diagnostic instruments) along with providing modern tools and “real-time” networking technologies that empower members to own, manage everyday operational, managerial and compliance processes by connecting healthcare and clinical research stakeholders with a focus on PATIENT CENTRIC CARE. Mr. Pacino is a past member of the Association of Clinical Research Professionals (ACRP) Editorial Advisory Board and past chair of the Central Texas Chapter. He previously served as the VP for Collaborative Network Development at ACRES, current leader at DTRA and proactively involved with the Society for Clinical Research Sites (SCRS) among many other leading global organizations. Actively involved in collaborations for global standardization of modern diagnostic programs with governments, universities, not for profits and other entities which are modernizing the healthcare and clinical research ecosystem, with a focus on education, standards of care, compliance, global General Data Protection Regulations (GDPR), and USA privacy Laws.

Specialties: He has previously introduced the phenomenon and coined the phrase “TrialDrift”, and along with other experts in the field has been able to bring to the forefront the issues, causes, consequences and solutions associated with such clinical research phenomenon. He has extensive experience with standardization, creation of collaborative networks and works alongside global industry leaders in governments, universities and not for profit organizations to eliminate redundancies, waste and abuse to minimized costs within the healthcare and clinical research industries and furthermore improve healthcare, drug, device and biotech development process in order to avoid data integrity / DATA VARIANCE issues in clinical trials, modernizing our Eco-system with the ultimate mission to #LeaveNoPatientBehindMr. Pacino is a well known industry KOL. A 16 year head and neck cancer survivor, a US Army veteran and a senior executive with over 35 years experience in healthcare and clinical research. Inventor GDPRWallet®, Trust&Verify on BlueCloud. Patient Diversity Advocate and Co-Founder and current President of BlueCloud by HealthCarePoint, a leading global PRIVACY / GDPR Based Network of over 2,100,000+ healthcare and clinical research professionals in the neurosciences, Cardiovascular, CNS and other therapeutic verticals, from more than 500,000+ organizations, focused on providing globally standardized training, education and certifications (NIH Stroke Scale, mRS Rankin, Suicidality (C-SSRS), Barthel Index (BI), + dozens more patient focused diagnostic instruments) along with providing modern tools and “real-time” networking technologies that empower members to own, manage everyday operational, managerial and compliance processes by connecting healthcare and clinical research stakeholders with a focus on PATIENT CENTRIC CARE. Mr. Pacino is a past member of the Association of Clinical Research Professionals (ACRP) Editorial Advisory Board and past chair of the Central Texas Chapter. He previously served as the VP for Collaborative Network Development at ACRES, current leader at DTRA and proactively involved with the Society for Clinical Research Sites (SCRS) among many other leading global organizations. Actively involved in collaborations for global standardization of modern diagnostic programs with governments, universities, not for profits and other entities which are modernizing the healthcare and clinical research ecosystem, with a focus on education, standards of care, compliance, global General Data Protection Regulations (GDPR), and USA privacy Laws. Specialties: He has previously introduced the phenomenon and coined the phrase “TrialDrift”, and along with other experts in the field has been able to bring to the forefront the issues, causes, consequences and solutions associated with such clinical research phenomenon. He has extensive experience with standardization, creation of collaborative networks and works alongside global industry leaders in governments, universities and not for profit organizations to eliminate redundancies, waste and abuse to minimized costs within the healthcare and clinical research industries and furthermore improve healthcare, drug, device and biotech development process in order to avoid data integrity / DATA VARIANCE issues in clinical trials, modernizing our Eco-system with the ultimate mission to #LeaveNoPatientBehind

Tina has had leadership roles with F500 companies as well as key roles within startups. Role expertise spans executive leadership, strategy, product development, operationalization, program management with P&L experience up to 10M USD. She has managed teams up to 50, both in the US and internationally, and understands operational scaling.

Her goal is to drive HealthcarePoint business units to optimal profitability via the intersection of doing well by doing good. Innovation, optimization, digital, health and wellness are her watch words.